Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Voyager Therapeutics, Inc. (VYGR)  
$7.62 0.20 (2.7%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,470,000
Market Cap: 285.52(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.28 - $13.99
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Voyager Therapeutics is a gene therapy company focused on developing treatments and platform technologies. Co.'s team has developed a proprietary adeno-associated virus (AAV) capsid discovery platform called TRACER™ (Tropism Redirection of AAV by Cell Type-Specific Expression of RNA) to facilitate the selection of AAV capsids with blood brain barrier crossing and cell-specific transduction properties for particular therapeutic applications. The TRACER discovery platform is a functional RNA-based AAV capsid discovery platform that allows for rapid in vivo evolution of AAV capsids with cell-specific transduction properties in multiple species, including non-human primates.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 4,872,988
Total Buy Value $0 $0 $0 $41,694,868
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 3
Total Shares Sold 38,202 42,011 76,578 2,756,162
Total Sell Value $317,473 $344,745 $641,708 $21,052,273
Total People Sold 4 4 4 9
Total Sell Transactions 7 9 13 45
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 162
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Swartz Robin Chief Operating Officer   •       –      –    2024-04-02 4 S $9.88 $13,407 D/D (1,357) 117,004 25%     
   Sandrock Alfred President and CEO   •       •      –    2024-04-02 4 S $9.86 $119,454 D/D (12,115) 322,839 25%     
   Ferguson Toby Chief Medical Officer   •       –      –    2024-04-01 4 A $0.00 $0 D/D 105,000 105,000     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2024-02-21 4 S $7.46 $28,079 D/D (3,764) 175,669 3%     
   Sandrock Alfred President and CEO   •       •      –    2024-02-21 4 S $7.46 $97,226 D/D (13,033) 334,954 3%     
   Swartz Robin Chief Operating Officer   •       –      –    2024-02-21 4 S $7.45 $29,547 D/D (3,966) 118,361 3%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2024-02-21 4 S $7.47 $25,137 D/D (3,365) 87,627 3%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2024-02-20 4 S $7.68 $4,623 D/D (602) 90,992 2%     
   Sandrock Alfred President and CEO   •       •      –    2024-02-09 4 A $0.00 $0 D/D 130,000 347,987     -
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 38,500 91,594     -
   Swartz Robin Chief Operating Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 50,000 122,327     -
   Fahey Sandell Jacquelyn Chief Legal Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 31,000 92,000     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 30,000 179,433     -
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2024-01-17 4 S $7.18 $9,090 D/D (1,266) 53,094 -2%     
   Swartz Robin Chief Operating Officer   •       –      –    2024-01-17 4 S $7.15 $18,182 D/D (2,543) 72,327 -2%     
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2023-10-03 4 S $6.99 $94,833 D/D (13,567) 149,433 -9%     
   Fahey Sandell Jacquelyn Chief Legal Officer   •       –      –    2023-10-01 4 A $0.00 $0 D/D 61,000 61,000     -
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2023-09-15 4 AS $8.16 $85,680 D/D (10,500) 54,360 -4%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2023-09-15 4 OE $2.85 $14,250 D/D 5,000 64,860     -
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2023-07-06 4 AS $10.80 $59,400 D/D (5,500) 59,860 -40%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2023-06-30 4 AS $11.41 $57,050 D/D (5,000) 65,360 -40%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2023-06-30 4 OE $2.85 $14,250 D/D 5,000 70,360     -
   Swartz Robin Chief Operating Officer   •       –      –    2023-04-03 4 S $7.83 $9,858 D/D (1,259) 71,617 -15%     
   Sandrock Alfred President and CEO   •       •      –    2023-04-03 4 S $7.83 $58,232 D/D (7,437) 214,618 -15%     
   Swartz Robin Chief Operating Officer   •       –      –    2023-03-20 4 AS $7.76 $28,355 D/D (3,654) 72,876 17%     
  162 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us